UK MHRA Relaxes GMP Rules For Drugs Imported From Third Countries During COVID-19 Outbreak

 
• By Neena Brizmohun

The regulatory agency also urges qualified persons at drug companies to let the agency know as soon as possible if they are finding that the new measures are not flexible enough to deal with the current logistical challenges quickly.

Science_Lab
New MHRA guidelines are designed to help QPs during the COVID-19 pandemic • Source: Shutterstock

More from Manufacturing

More from Compliance